2002
DOI: 10.1016/s0165-1781(02)00127-0
|View full text |Cite
|
Sign up to set email alerts
|

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

13
128
0
5

Year Published

2005
2005
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 262 publications
(146 citation statements)
references
References 39 publications
13
128
0
5
Order By: Relevance
“…Although population studies have yielded divergent data about the association of variants in the BDNF gene with increased risk and developmental features of schizophrenia, [72][73][74][75][76][77][78] human postmortem studies suggest that individuals with schizophrenia have reduced expression of TrkB and BDNF in the cerebral cortex, 12,[79][80][81][82] as well as decreased BDNF protein levels in the serum. 83 In addition, various animal models of schizophrenia consistently show a downregulation of BDNF transcript or protein. 4,[75][76][77][78][84][85][86][87][88] Importantly, just as in our current study of BDNF- ablated animals, SST, NPY and RGS4 transcripts are downregulated in the prefrontal cortex (PFC) of subjects with schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…Although population studies have yielded divergent data about the association of variants in the BDNF gene with increased risk and developmental features of schizophrenia, [72][73][74][75][76][77][78] human postmortem studies suggest that individuals with schizophrenia have reduced expression of TrkB and BDNF in the cerebral cortex, 12,[79][80][81][82] as well as decreased BDNF protein levels in the serum. 83 In addition, various animal models of schizophrenia consistently show a downregulation of BDNF transcript or protein. 4,[75][76][77][78][84][85][86][87][88] Importantly, just as in our current study of BDNF- ablated animals, SST, NPY and RGS4 transcripts are downregulated in the prefrontal cortex (PFC) of subjects with schizophrenia.…”
Section: Discussionmentioning
confidence: 99%
“…This hypothesis is supported by studies showing that NGF and BDNF are abnormally regulated in the CNS of animal models of schizophrenia, [53][54][55][56]13,57 and by the findings that schizophrenic patients have reduced number of TrkB and BDNF-positive neurons 5 and BDNF in the serum. 6 Results from studies on human post-mortem tissues from schizophrenic patients show a significant decrease in BDNF concentrations in cortical areas and the hippocampus, 4 whereas other authors have reported that BDNF protein is elevated in the anterior cingulated cortex and hippocampus of schizophrenics. 58 These data were taken as further evidence for the hypothesis that alterations in the expression of neurotrophins participate in the neural maldevelopment and the disturbed neural plasticity in schizophrenic patients.…”
Section: Animal Modelsmentioning
confidence: 98%
“…Studies on post-mortem Human Decreased BDNF concentrations in cortical areas and hippocampus of schizophrenic patients 4 Reduction of TrkB and BDNF-positive neurons in CNS 5 and BDNF in the serum 6 of schizophrenics Polymorphisms of BDNF gene associated with schizophrenia [7][8][9] Animal models…”
Section: Bdnf and Schizophreniamentioning
confidence: 99%
“…Jockers-Scherübl et al 21 19 , a qual confirma que o mecanismo de ação de alguns fármacos antidepressivos seria provocar elevação nos níveis de neurotrofinas como forma de combater a depressão, outro transtorno psicológico. Além disso, Toyooka et al 22 verificaram aumentos dos níveis de BDNF em ratos tratados durante cinco meses com antipsicóticos como o haloperidol. No entanto, Jockers-Scherübl et al 21 não conseguiram determinar o motivo pelo qual os pacientes esquizofrênicos não usuários de Cannabis não apresentaram diferenças com relação aos indivíduos controles saudáveis.…”
Section: Alterações Nos Níveis Séricos De Neurotrofinas E Marcadores unclassified
“…No entanto, Jockers-Scherübl et al 21 não conseguiram determinar o motivo pelo qual os pacientes esquizofrênicos não usuários de Cannabis não apresentaram diferenças com relação aos indivíduos controles saudáveis. Por exemplo, os pacientes esquizofrênicos poderiam apresentar baixos níveis de neurotrofina por apresentarem reduções nos níveis de plaquetas, que são estruturas que contêm grande quantidade de neurotrofina 22,23 , e o aumento verificado de NGF nos grupos consumidores de Cannabis poderia estar elevado antes do início da doença ou foi posteriormente reforçada pelo consumo consorciado da Cannabis. Apesar das dúvidas existentes, os resultados demonstram que as concentrações séricas de NGF em esquizofrênicos diferem grandemente do consumo prolongado de drogas ilícitas.…”
Section: Alterações Nos Níveis Séricos De Neurotrofinas E Marcadores unclassified